AmpR |
A LysR-type global transcriptional regulator controlling the expression of ampC and other genes related to virulence, quorum sensing, biofilm formation, etc. |
P. aeruginosa |
A significant reduction of the ability to kill Caenorhabditis elegans with AmpR inactivation; with the G154R AmpR mutation, prevalent in the ST175 high-risk clone, reduced virulence in the same model of infection |
267 |
CreBC/CreD |
For CreBC, a two-component system and global metabolic regulator involved in the response against stress or biofilm growth, among others; for CreD an inner membrane effector protein of the CreBC system |
P. aeruginosa |
A decrease in fitness in in vitro competition experiments compared with that of the wild type, mainly in the presence of β-lactams; a decrease in the formation of biofilms, mainly in the presence of β-lactams; decrease of exoS expression, especially in the presence of ceftazidime |
276 |
AmpD-AmpDh2-AmpDh3 |
N-Acetyl-anhydromuramyl-l-alanine amidases that are involved in PGN turnover and recycling as well as AmpC repression and that are cytoplasmic (AmpD) or periplasmic and involved in stem peptide cleavage (AmpDh2 and AmpDh3) |
P. aeruginosa |
Severely compromised growth rates, motility, and cytotoxicity in the triple mutant; repression in key virulence factors, such as protease LasA, phospholipase C, or T3SS components; decreased virulence of circa 100-fold in Galleria mellonella model |
223 |
NagZ, AmpG, and AmpD-AmpDh2-AmpDh3 |
Key elements allowing PGN recycling (see the text for further details) |
P. aeruginosa |
Increased susceptibility to lysozyme and human PGRPs; if PGN blockade is combined with AmpC hyperproduction (for the AmpD-AmpDh2-AmpDh3 triple mutant), an even higher increase in susceptibility to lysozyme and PGRP2 specifically |
203 |
CreBC |
A two-component system and global metabolic regulator involved in the response against stress |
S. maltophilia |
A decrease in secreted protease activity |
277 |
AmpD |
A cytosolic 1,6-anhydro-N-acetylmuramyl– l-alanine amidase cleaving the stem peptide from 1,6-anhydro-N-acetylmuramic acid in a key step for PGN recycling |
Salmonella enterica serovar Typhimurium |
Upregulation during infection; in a knockout mutant, a decreased capacity to invade macrophages and more potent induction of the nitric oxide response of bacterial killing; decreased competitiveness in a BALB/c mouse model of infection |
85, 99
|
AmpD |
A cytosolic 1,6-anhydro-N-acetylmuramyl–l-alanine amidase involved in PGN recycling |
N. meningitidis |
An inability to cause systemic infection in an infant rat model; in wild-type strains, hyperexpression of AmpD during infection |
84 |
AmpD |
A cytosolic 1,6-anhydro-N-acetylmuramyl–l-alanine amidase cleaving the stem peptide from 1,6-anhydro-N-acetylmuramic acid in a key step for PGN recycling |
Ralstonia solanacearum |
Upregulation during infection; in a knockout mutant, reduced virulence in eggplant and tomato models |
85, 98
|
NagZxc |
A β-N-acetylglucosaminidase that cleaves the bond between 1,6-anhydro-N-acetylmuramic acid and N-acetylglucosamine |
X. campestris |
Reduced average lesion areas in cabbage infection model |
232 |
AmpGxc |
A specific permease for PGN fragments containing the disaccharide N-acetylmuramic acid–N-acetylglucosamine |
X. campestris |
Slightly increased average lesion areas in cabbage infection model |
232 |
AmpC |
A class C β-lactamase (noninducible due to the lack of the AmpR regulator in E. coli) |
E. coli |
In AmpH-AmpC double mutants, uneven contours and aberrant and asymmetric constrictions between dividing cells |
255 |